-
公开(公告)号:US07241793B2
公开(公告)日:2007-07-10
申请号:US10518347
申请日:2003-06-18
IPC分类号: A61K31/415 , A61K31/4155 , C07D231/38 , C07D231/12
CPC分类号: C07D231/12 , C07D231/38 , C07D271/06 , C07D277/28 , C07D277/42 , C07D409/12 , C07D417/12
摘要: A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein:
摘要翻译: 式(I)化合物或其药学上可接受的盐,溶剂合物或可水解的酯,其中:
-
2.
公开(公告)号:US08557984B2
公开(公告)日:2013-10-15
申请号:US13503722
申请日:2010-11-03
申请人: Anne Marie Jeanne Bouillot , Frederic Donche , Francoise Jeanne Gellibert , Yann Lamotte , Olivier Mirguet
发明人: Anne Marie Jeanne Bouillot , Frederic Donche , Francoise Jeanne Gellibert , Yann Lamotte , Olivier Mirguet
IPC分类号: C07D471/04 , C07D471/14
CPC分类号: C07D471/04
摘要: Novel compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
摘要翻译: 新型式(I)化合物及其盐,含有这些化合物的药物组合物及其在治疗中的用途。
-
3.
公开(公告)号:US07157479B2
公开(公告)日:2007-01-02
申请号:US10478936
申请日:2002-05-29
IPC分类号: A61K31/426 , C07D277/30
CPC分类号: C07D277/56
摘要: A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof Wherein X1 represents O or S; R1 and R2 are independently H or C1-3 alkyl or R1 and R2 which are bonded to the same carbon atom may together with the carbon atom to which they are bonded form a 3–5 membered cycloalkyl ring; R3 and R4 independently represent H, halogen, —CH3 and —OCH3; R5 represents H or C1-6 alkyl X2 represents NH, NCH3 or O; One of Y and Z is N, and the other is O or S; R6 represents phenyl or pyridyl (wherein the N is in position 2 or 3) and is optionally substituted by one or more halogen, CF3, C1-6 straight or branched alkyl (optionally substituted by halogen), with the provision that when R6 is pyridyl, the N is unsubstituted.
摘要翻译: 式(I)的化合物及其药学上可接受的盐,溶剂合物和可水解的酯。其中X 1代表O或S; R 1和R 2独立地是H或C 1-3烷基或R 1和R 2, 2个与相同碳原子键合的2个可以与它们所键合的碳原子一起形成3-5元环烷基环; R 3和R 4独立地表示H,卤素,-CH 3 3和-OCH 3 3; R 5表示H或C 1-6烷基,X 2表示NH,NCH 3或O; Y和Z之一是N,另一个是O或S; R 6表示苯基或吡啶基(其中N在位置2或3),并且任选被一个或多个卤素,CF 3,C 1〜 6个直链或支链烷基(任选被卤素取代),条件是当R 6为吡啶基时,N为未取代的。
-
4.
公开(公告)号:US20120232074A1
公开(公告)日:2012-09-13
申请号:US13503722
申请日:2010-11-03
申请人: Anne Marie Jeanne Bouillot , Frederic Donche , Francoise Jeanne Gellibert , Yann Lamotte , Olivier Mirguet
发明人: Anne Marie Jeanne Bouillot , Frederic Donche , Francoise Jeanne Gellibert , Yann Lamotte , Olivier Mirguet
IPC分类号: A61K31/5377 , A61K31/437 , A61P37/00 , A61K31/506 , A61P35/00 , C07D471/14 , A61K31/497 , C07D471/04 , A61P29/00
CPC分类号: C07D471/04
摘要: Novel compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
摘要翻译: 新型式(I)化合物及其盐,含有这些化合物的药物组合物及其在治疗中的用途。
-
-
-